Strain Information | |
---|---|
Image | ![]() |
BRC No. | RBRC01420 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6;129P2-Irf7<tm1Ttg>/TtgRbrc |
Former Common name | IRF-7-KO, IRF7, IRF-7 knockout mice, C57BL/6J |
H-2 Haplotype | |
ES Cell line | E14.1 [129P2/OlaHsd] |
Background strain | C57BL/6J |
Appearance | black [a/a] |
Strain development | Developed by Kenya Honda and Tadatsugu Taniguchi, Graduate School of Medicine and Faculty of Medicine, University of Tokyo in 2001. The knockout construct was electroporated into E14 ES cells derived from 129P2/OlaHsd. C57BL/6 semicongenic strain. |
Strain description | IRF7 knockout mice. Exon 2 and 3 of Irf7 gene were replaced with a PGK-beta-geo cassette. Homozygous mutant mice are vulnerable to viral infection with a decreased serum interferon level. |
Colony maintenance | Homozygote x Homozygote |
References | IRF-7 is the master regulator of type-I interferon-dependent immune responses. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T Nature, 434, 772-777 (2005). 15800576 |
Health Report | |
---|---|
Examination Date / Room / Rack | 2024/11/25Room:4-BRack:LSentinel mouse program 2024/08/26Room:4-BRack:LSentinel mouse program 2024/05/27Room:4-BRack:LSentinel mouse program 2024/02/26Room:4-BRack:LSentinel mouse program 2023/11/27Room:4-BRack:LSentinel mouse program 2023/09/28Room:4-BRack:LAdditional tests 2023/08/28Room:4-BRack:LSentinel mouse program 2023/05/29Room:4-BRack:LSentinel mouse program |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Irf7 MGI:1859212 | interferon regulatory factor 7 | 7 | Irf7<tm1Ttg> MGI:3577089 | targeted mutation 1, Tadatsugu Taniguchi | |||
lacZ | beta-galactosidase (E. coli) | 7 | mouse phosphoglycerate kinase promoter (PGK promoter) | ||||
neo | neomycin resistance gene (E. coli) | 7 |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase promoter (PGK promoter), E. coli beta-geo gene (E. coli neo, E. coli lacZ), mouse IRF-7 genomic DNA |
Research application | Fluorescent Proteins/lacZ System |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. |
Depositor | Tadatsugu Taniguchi (The University of Tokyo) |
Strain Status | ![]() ![]() ![]() |
Strain Availability | Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) Live mouse (1 to 3 months) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- Mouse of the Month May 2005 |
BRC mice in Publications |
---|
Sepahpour T, Alshaweesh J, Azodi N, Singh K, Ireland DDC, Valanezhad F, Nakamura R, Satoskar AR, Dey R, Hamano S, Nakhasi HL, Gannavaram S. Downregulation of IRF7-mediated type-I interferon response by LmCen-/- parasites is necessary for protective immunity. NPJ Vaccines 9(1) 250(2024) 39702382 |
Yalong Yang, Vishnu Kumar, Wei Peng, Monika Fijak, Michel Gabriela, Wei Cai, Andreas Meinhardt, Sudhanshu Bhushan Role of Macrophage Colony Stimulating Factor and Interferon Regulatory Factor 7 in Modulating the Immune Profile of Mouse Testicular Macrophages Journal of Reproductive Immunology 104169(2023) |
Zhang Z, Mai Q, Yang L, Chen Y, Chen Z, Lin T, Tan S, Wu Z, Cai Y, Cui T, Ouyang B, Yang Y, Zeng L, Ge Z, Zhang S, Zeng G, Pi J, Chen L. MicroRNA-31 mediated by interferon regulatory factor 7 signaling facilitates control of Mycobacterium tuberculosis infection. Int J Med Microbiol 312(7) 151569(2022) 36274382 |
Sin WX, Yeong JP, Lim TJF, Su IH, Connolly JE, Chin KC. IRF-7 Mediates Type I IFN Responses in Endotoxin-Challenged Mice. Front Immunol 11 640(2020) 32373120 |
Kuroda M, Nishiguchi M, Ugawa N, Ishikawa E, Kawabata Y, Okamoto S, Sasaki W, Miyatake Y, Sebe M, Masumoto S, Tsutsumi R, Harada N, Sakaue H. Interferon regulatory factor 7 mediates obesity-associated MCP-1 transcription. PLoS One 15(5) e0233390(2020) 32437400 |
Elsaesser HJ, Mohtashami M, Osokine I, Snell LM, Cunningham CR, Boukhaled GM, McGavern DB, Zúñiga-Pflücker JC, Brooks DG. Chronic virus infection drives CD8 T cell-mediated thymic destruction and impaired negative selection. Proc Natl Acad Sci U S A 117(10) 5420-5429(2020) 32094187 |
Puthia M, Ambite I, Cafaro C, Butler D, Huang Y, Lutay N, Rydström G, Gullstrand B, Swaminathan B, Nadeem A, Nilsson B, Svanborg C. IRF7 inhibition prevents destructive innate immunity-A target for nonantibiotic therapy of bacterial infections. Sci Transl Med 8(336) 336ra59(2016) 27122612 |
Temizoz B, Kuroda E, Ohata K, Jounai N, Ozasa K, Kobiyama K, Aoshi T, Ishii KJ. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. Eur J Immunol 45(4) 1159-69(2015) 25529558 |
Li W, Hofer MJ, Jung SR, Lim SL, Campbell IL. IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus. J Virol 88(13) 7578-88(2014) 24760883 |
Wang XA, Zhang R, Zhang S, Deng S, Jiang D, Zhong J, Yang L, Wang T, Hong S, Guo S, She ZG, Zhang XD, Li H. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance. Am J Physiol Endocrinol Metab 305(4) E485-95(2013) 23695216 |
Li W, Hofer MJ, Noçon AL, Manders P, Campbell IL. Interferon regulatory factor 7 (IRF7) is required for the optimal initial control but not subsequent clearance of lymphocytic choriomeningitis virus infection in mice. Virology 439(2) 152-62(2013) 23490048 |
Zhou S, Cerny AM, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection. J Virol 86(20) 11254-65(2012) 22875973 |
Christensen JE, Fenger C, Issazadeh-Navikas S, Krug A, Liljestrøm P, Goriely S, Paludan SR, Finsen B, Christensen JP, Thomsen AR. Differential impact of interferon regulatory factor 7 in initiation of the type I interferon response in the lymphocytic choriomeningitis virus-infected central nervous system versus the periphery. J Virol 86(13) 7384-92(2012) 22514347 |
Beattie L, Phillips R, Brown N, Owens BM, Chauhan N, Dalton JE, Kaye PM. Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver. Infect Immun 79(3) 1057-66(2011) 21149596 |
Prantner D, Sikes JD, Hennings L, Savenka AV, Basnakian AG, Nagarajan UM. Interferon regulatory transcription factor 3 protects mice from uterine horn pathology during Chlamydia muridarum genital infection. Infect Immun 79(10) 3922-33(2011) 21788382 |
Salem M, Mony JT, Løbner M, Khorooshi R, Owens T. Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. J Neuroinflammation 8 181(2011) 22196084 |
Marichal T, Bedoret D, Mesnil C, Pichavant M, Goriely S, Trottein F, Cataldo D, Goldman M, Lekeux P, Bureau F, Desmet CJ. Interferon response factor 3 is essential for house dust mite-induced airway allergy. J Allergy Clin Immunol 126(4) 836-844.e13(2010) 20673978 |
Khorooshi R, Owens T. Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 185(2) 1258-64(2010) 20562259 |
Prantner D, Darville T, Nagarajan UM. Stimulator of IFN gene is critical for induction of IFN-beta during Chlamydia muridarum infection. J Immunol 184(5) 2551-60(2010) 20107183 |
Molle C, Goldman M, Goriely S. Critical role of the IFN-stimulated gene factor 3 complex in TLR-mediated IL-27p28 gene expression revealing a two-step activation process. J Immunol 184(4) 1784-92(2010) 20083668 |
Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Induction and inhibition of type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J Virol 84(18) 9452-62(2010) 20592086 |
Phillips R, Svensson M, Aziz N, Maroof A, Brown N, Beattie L, Signoret N, Kaye PM. Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7. PLoS Pathog 6(3) e1000813(2010) 20300600 |
Giordano G, van den Brûle S, Lo Re S, Triqueneaux P, Uwambayinema F, Yakoub Y, Couillin I, Ryffel B, Michiels T, Renauld JC, Lison D, Huaux F. Type I interferon signaling contributes to chronic inflammation in a murine model of silicosis. Toxicol Sci 116(2) 682-92(2010) 20513754 |
Abe T, Kaname Y, Wen X, Tani H, Moriishi K, Uematsu S, Takeuchi O, Ishii KJ, Kawai T, Akira S, Matsuura Y. Baculovirus induces type I interferon production through toll-like receptor-dependent and -independent pathways in a cell-type-specific manner. J Virol 83(15) 7629-40(2009) 19474102 |
Kinpara S, Hasegawa A, Utsunomiya A, Nishitsuji H, Furukawa H, Masuda T, Kannagi M. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon. J Virol 83(10) 5101-8(2009) 19264779 |
Yasuda K, Richez C, Maciaszek JW, Agrawal N, Akira S, Marshak-Rothstein A, Rifkin IR. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 178(11) 6876-85(2007) 17513736 |